Patent Application
Utility
App. No. 17/489,939
· Confirmation No. 1872
PHARMACEUTICAL FORMULATIONS USEFUL FOR INHIBITING ACID SECRETION AND METHODS FOR MAKING AND USING THEM
Applicant:
Santarus, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-11-25 | ABN |
Abandonment | 2 | View | |
| 2025-05-23 | OA.POSTCARD |
A courtesy postcard sent by USPTO to users who opt-in for e-Office Action | 1 | View | |
| 2025-05-16 | CTFR |
Final Rejection | 13 | View | |
| 2025-05-16 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-05-16 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-05-16 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-05-08 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-05-02 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2025-05-02 | CLM |
Claims | 1 | View | |
| 2025-05-02 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2025-05-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-05-02 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 5 | View | |
| 2025-05-02 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-02-07 | OA.POSTCARD |
A courtesy postcard sent by USPTO to users who opt-in for e-Office Action | 1 | View | |
| 2025-01-31 | CTNF |
Non-Final Rejection | 11 | View | |
| 2025-01-31 | 892 |
List of references cited by examiner | 1 | View | |
| 2025-01-31 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-01-31 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2025-01-31 | FOR |
Foreign Reference | 24 | View | |
| 2025-01-31 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2024-06-05 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-05-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-05-23 | PA.. |
Power of Attorney | 1 | View | |
| 2022-05-05 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-01-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-01-26 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2022-01-26 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-01-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-01-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-01-24 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2022-01-24 | LET. |
Miscellaneous Incoming Letter | 3 | View | |
| 2022-01-24 | SPEC |
Specification | 116 | View | |
| 2022-01-24 | DRW.NONBW |
Drawings-other than black and white line drawings | 12 | View | |
| 2022-01-24 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-01-24 | SPEC |
Specification | 1 | View | |
| 2022-01-24 | CLM |
Claims | 1 | View | |
| 2022-01-24 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-01-24 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2022-01-24 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2021-10-14 | NTC.MISS.PRT |
Notice to File Missing Parts | 3 | View | |
| 2021-10-14 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-10-14 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-09-30 | TRNA |
Transmittal of New Application | 2 | View | |
| 2021-09-30 | ADS |
Application Data Sheet | 9 | View | |
| 2021-09-30 | OATH |
Oath or Declaration filed | 3 | View | |
| 2021-09-30 | DRW |
Drawings-only black and white line drawings | 24 | View | |
| 2021-09-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2021-09-30 | SPEC |
Specification | 116 | View | |
| 2021-09-30 | CLM |
Claims | 1 | View | |
| 2021-09-30 | ABST |
Abstract | 1 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
514/451
A61K33/00
A61K9/0056
A61K9/0095
A61K9/2018
A61K9/2031
A61K9/2054
A61K9/2072
A61K9/48
A61K9/4858
A61K9/4866
A61K31/4439
A61K33/08
Prosecution
- Examiner
- IVANOVA, SVETLANA M
- Art Unit
- 1627
- Customer No.
- 199517
- Docket No.
- 20215.0037.CNUS03
- Confirmation No.
- 1872
Publication
- Pub. No.
- US20220133778A1
- Pub. Date
- 2022-05-05
Parent
is a Continuation of
→
App. 16/138,859
Filed 2018-09-21
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 14/467,741
Filed 2014-08-25
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 11/287,888
· US 8,815,916
Filed 2005-11-28
· Patented Case
Parent
is a Continuation in-part of
→
App. 11/138,763
· US 8,906,940
Filed 2005-05-25
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/574,663
Filed 2004-05-25
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 60/574,646
Filed 2004-05-25
· Provisional Application Expired
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-10-05
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-10-04
SECURITY INTEREST
Recorded 2022-09-16
SECURITY INTEREST
Recorded 2022-09-16
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH US, LLC,
BAUSCH+LOMB IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.,
SOLTA MEDICAL IRELAND LIMITED,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-11-24
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2021-09-30
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/489,939
- Filed
- 2021-09-30
- Pub. No.
- US20220133778A1
- Examiner
- IVANOVA, SVETLANA M
- Art Unit
- 1627
External Links